These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 11313005)

  • 1. Biology and disease associations of Epstein-Barr virus.
    Crawford DH
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):461-73. PubMed ID: 11313005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBV and genomic instability--a new look at the role of the virus in the pathogenesis of Burkitt's lymphoma.
    Gruhne B; Kamranvar SA; Masucci MG; Sompallae R
    Semin Cancer Biol; 2009 Dec; 19(6):394-400. PubMed ID: 19619655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma.
    Shah KM; Young LS
    Clin Microbiol Infect; 2009 Nov; 15(11):982-8. PubMed ID: 19874382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burkitt's Lymphoma.
    Rochford R; Moormann AM
    Curr Top Microbiol Immunol; 2015; 390(Pt 1):267-85. PubMed ID: 26424650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of EBV in microRNA dysregulation in Burkitt lymphoma.
    De Falco G; Antonicelli G; Onnis A; Lazzi S; Bellan C; Leoncini L
    Semin Cancer Biol; 2009 Dec; 19(6):401-6. PubMed ID: 19619656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus: 40 years on.
    Young LS; Rickinson AB
    Nat Rev Cancer; 2004 Oct; 4(10):757-68. PubMed ID: 15510157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.
    Rowe M; Kelly GL; Bell AI; Rickinson AB
    Semin Cancer Biol; 2009 Dec; 19(6):377-88. PubMed ID: 19619657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-associated lymphomas.
    Shannon-Lowe C; Rickinson AB; Bell AI
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reflections on Epstein-Barr virus: some recently resolved old uncertainties.
    Epstein MA
    J Infect; 2001 Aug; 43(2):111-5. PubMed ID: 11676516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
    De Leo A; Arena G; Stecca C; Raciti M; Mattia E
    Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFkappaB pathway.
    Vockerodt M; Tesch H; Kube D
    Genes Immun; 2001 Dec; 2(8):433-41. PubMed ID: 11781710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.
    Klein G; Klein E; Kashuba E
    Biochem Biophys Res Commun; 2010 May; 396(1):67-73. PubMed ID: 20494113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
    J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endemic Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus.
    Chene A; Donati D; Orem J; Mbidde ER; Kironde F; Wahlgren M; Bejarano MT
    Semin Cancer Biol; 2009 Dec; 19(6):411-20. PubMed ID: 19897039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV) association and latency profile in pediatric Burkitt's lymphoma: experience of a single institution in Argentina.
    Lara J; Cohen M; De Matteo E; Aversa L; Preciado MV; Chabay P
    J Med Virol; 2014 May; 86(5):845-50. PubMed ID: 24027016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of cell differentiation, one of the mechanisms in the surveillance of malignancy.
    Klein E; Nagy N; Rasul E
    Cancer Immunol Res; 2015 Feb; 3(2):97-102. PubMed ID: 25660552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Epstein-Barr Virus infection in immunocompromised patients.
    Pociupany M; Snoeck R; Dierickx D; Andrei G
    Biochem Pharmacol; 2024 Jul; 225():116270. PubMed ID: 38734316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus (EBV) and human disease: facts, opinions and problems.
    Griffin BE
    Mutat Res; 2000 Apr; 462(2-3):395-405. PubMed ID: 11523539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Burkitt's lymphoma to chronic active Epstein-Barr virus (EBV) infection: an expanding spectrum of EBV-associated diseases.
    Okano M; Gross TG
    Pediatr Hematol Oncol; 2001; 18(7):427-42. PubMed ID: 11594706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epstein-Barr virus (EBV)].
    Seigneurin JM
    Rev Prat; 1999 Dec; 49(20):2217-21. PubMed ID: 10731805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.